Reviews FDG


No reviews yet.

Fludeoxyglucose F 18 Injection Drug Description
Fludeoxyglucose F 18 Injection
(FDG)
Diagnostic - For Intravenous Use Only
DRUG DESCRIPTION
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing
no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which
is used for diagnostic purposes in conjunction with Positron Emission Tomography
(PET). It is administered by intravenous injection.
The active ingredient 2-deoxy-2-[18F]fluoro-D-g1ucose (Fludeoxyglucose
F 18), abbreviated [18F] FDG, has a molecular formula of C6H1118FO5
with a molecular weight of 181.26 daltons, and has the following chemical structure:








Fludeoxyglucose F 18 Injection is provided as a ready to use isotonic, sterile,
pyrogen free, clear, colorless citrate buffered solution. Each mL contains between
0.37 to 3.7 GBq (10.0 - 100 mCi) of 2-deoxy-2-[18F]fluoro-D glucose
at the end of synthesis (EOS), 4.5 mg of sodium chloride and 7.2 mg of citrate
ions. The pH of the solution is between 5.0 to 7.5. The solution is packaged
in a multiple-dose glass vial and does not contain any preservative.
Physical Characteristics
Fluorine F 18 decays by positron (β+) emission and has a half-life
of 109.7 minutes. The principal photons useful for diagnostic imaging are the
511 keV gamma photons, resulting from the interaction of the emitted positron
with an electron (Table 1).
Table 1. Principal Emission Data for Fluorine F 18



Radiation/Emission
% per Disintegration
Mean Energy


Positron (β+)
96.73
249.8 keV


Gamma (±)*
193.46
511.0 keV


*Produced by positron annihilation
From: Kocher, D.C. "Radioactive Decay Tables" DOE/TIC-11026, 89 (1981).



External Radiation
The specific gamma ray constant for fluorine F 18 is 6.0 R/hr/mCi (0.3 Gy/hr/kB) at 1cm. The half-value layer (HVL) for the 511 keV photons is 4.1 mm lead (Pb). A range of values for the attenuation of radiation results from the interposition of various thickness of Pb. The range of attenuation coefficients for this radionuclide is shown in Table 2. For example, the interposition of an 8.3 mm thickness of Pb, with a coefficient of attenuation of 0.25, will decrease the external radiation by 75%.
Table 2. Radiation Attenuation of 511 keV Photons by Lead
(Pb) Shielding



Shield Thickness (Pb) mm
Coefficient of Attenuation


0
0.00


4.1
0.50


8.3
0.25


13.2
0.10


26.4
0.01


52.8
0.001



For use in correcting for physical decay of this radionuclide, the fractions remaining at selected intervals after calibration are shown in Table 3.
Table 3. Physical Decay Chart for Fluorine F 18



Minutes
Fraction Remaining


0*
1.00


15
0.909


30
0.826


60
0.683


110
0.500


220
0.250


440
0.060


* Calibration time


Last reviewed on RxList: 9/15/2008




Fludeoxyglucose F 18 Injection Drug Description
Fludeoxyglucose F 18 Injection
(FDG)
Diagnostic - For Intravenous Use Only
DRUG DESCRIPTION
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing
no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which
is used for diagnostic purposes in conjunction with Positron Emission Tomography
(PET). It is administered by intravenous injection.
The active ingredient 2-deoxy-2-[18F]fluoro-D-g1ucose (Fludeoxyglucose
F 18), abbreviated [18F] FDG, has a molecular formula of C6H1118FO5
with a molecular weight of 181.26 daltons, and has the following chemical structure:








Fludeoxyglucose F 18 Injection is provided as a ready to use isotonic, sterile,
pyrogen free, clear, colorless citrate buffered solution. Each mL contains between
0.37 to 3.7 GBq (10.0 - 100 mCi) of 2-deoxy-2-[18F]fluoro-D glucose
at the end of synthesis (EOS), 4.5 mg of sodium chloride and 7.2 mg of citrate
ions. The pH of the solution is between 5.0 to 7.5. The solution is packaged
in a multiple-dose glass vial and does not contain any preservative.
Physical Characteristics
Fluorine F 18 decays by positron (β+) emission and has a half-life
of 109.7 minutes. The principal photons useful for diagnostic imaging are the
511 keV gamma photons, resulting from the interaction of the emitted positron
with an electron (Table 1).
Table 1. Principal Emission Data for Fluorine F 18



Radiation/Emission
% per Disintegration
Mean Energy


Positron (β+)
96.73
249.8 keV


Gamma (±)*
193.46
511.0 keV


*Produced by positron annihilation
From: Kocher, D.C. "Radioactive Decay Tables" DOE/TIC-11026, 89 (1981).



External Radiation
The specific gamma ray constant for fluorine F 18 is 6.0 R/hr/mCi (0.3 Gy/hr/kB) at 1cm. The half-value layer (HVL) for the 511 keV photons is 4.1 mm lead (Pb). A range of values for the attenuation of radiation results from the interposition of various thickness of Pb. The range of attenuation coefficients for this radionuclide is shown in Table 2. For example, the interposition of an 8.3 mm thickness of Pb, with a coefficient of attenuation of 0.25, will decrease the external radiation by 75%.
Table 2. Radiation Attenuation of 511 keV Photons by Lead
(Pb) Shielding



Shield Thickness (Pb) mm
Coefficient of Attenuation


0
0.00


4.1
0.50


8.3
0.25


13.2
0.10


26.4
0.01


52.8
0.001



For use in correcting for physical decay of this radionuclide, the fractions remaining at selected intervals after calibration are shown in Table 3.
Table 3. Physical Decay Chart for Fluorine F 18



Minutes
Fraction Remaining


0*
1.00


15
0.909


30
0.826


60
0.683


110
0.500


220
0.250


440
0.060


* Calibration time


Last reviewed on RxList: 9/15/2008




Fludeoxyglucose F 18 Injection Drug Description
Fludeoxyglucose F 18 Injection
(FDG)
Diagnostic - For Intravenous Use Only
DRUG DESCRIPTION
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing
no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which
is used for diagnostic purposes in conjunction with Positron Emission Tomography
(PET). It is administered by intravenous injection.
The active ingredient 2-deoxy-2-[18F]fluoro-D-g1ucose (Fludeoxyglucose
F 18), abbreviated [18F] FDG, has a molecular formula of C6H1118FO5
with a molecular weight of 181.26 daltons, and has the following chemical structure:








Fludeoxyglucose F 18 Injection is provided as a ready to use isotonic, sterile,
pyrogen free, clear, colorless citrate buffered solution. Each mL contains between
0.37 to 3.7 GBq (10.0 - 100 mCi) of 2-deoxy-2-[18F]fluoro-D glucose
at the end of synthesis (EOS), 4.5 mg of sodium chloride and 7.2 mg of citrate
ions. The pH of the solution is between 5.0 to 7.5. The solution is packaged
in a multiple-dose glass vial and does not contain any preservative.
Physical Characteristics
Fluorine F 18 decays by positron (β+) emission and has a half-life
of 109.7 minutes. The principal photons useful for diagnostic imaging are the
511 keV gamma photons, resulting from the interaction of the emitted positron
with an electron (Table 1).
Table 1. Principal Emission Data for Fluorine F 18



Radiation/Emission
% per Disintegration
Mean Energy


Positron (β+)
96.73
249.8 keV


Gamma (±)*
193.46
511.0 keV


*Produced by positron annihilation
From: Kocher, D.C. "Radioactive Decay Tables" DOE/TIC-11026, 89 (1981).



External Radiation
The specific gamma ray constant for fluorine F 18 is 6.0 R/hr/mCi (0.3 Gy/hr/kB) at 1cm. The half-value layer (HVL) for the 511 keV photons is 4.1 mm lead (Pb). A range of values for the attenuation of radiation results from the interposition of various thickness of Pb. The range of attenuation coefficients for this radionuclide is shown in Table 2. For example, the interposition of an 8.3 mm thickness of Pb, with a coefficient of attenuation of 0.25, will decrease the external radiation by 75%.
Table 2. Radiation Attenuation of 511 keV Photons by Lead
(Pb) Shielding



Shield Thickness (Pb) mm
Coefficient of Attenuation


0
0.00


4.1
0.50


8.3
0.25


13.2
0.10


26.4
0.01


52.8
0.001



For use in correcting for physical decay of this radionuclide, the fractions remaining at selected intervals after calibration are shown in Table 3.
Table 3. Physical Decay Chart for Fluorine F 18



Minutes
Fraction Remaining


0*
1.00


15
0.909


30
0.826


60
0.683


110
0.500


220
0.250


440
0.060


* Calibration time


Last reviewed on RxList: 9/15/2008




Fludeoxyglucose F 18 Injection Drug Description
Fludeoxyglucose F 18 Injection
(FDG)
Diagnostic - For Intravenous Use Only
DRUG DESCRIPTION
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing
no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which
is used for diagnostic purposes in conjunction with Positron Emission Tomography
(PET). It is administered by intravenous injection.
The active ingredient 2-deoxy-2-[18F]fluoro-D-g1ucose (Fludeoxyglucose
F 18), abbreviated [18F] FDG, has a molecular formula of C6H1118FO5
with a molecular weight of 181.26 daltons, and has the following chemical structure:








Fludeoxyglucose F 18 Injection is provided as a ready to use isotonic, sterile,
pyrogen free, clear, colorless citrate buffered solution. Each mL contains between
0.37 to 3.7 GBq (10.0 - 100 mCi) of 2-deoxy-2-[18F]fluoro-D glucose
at the end of synthesis (EOS), 4.5 mg of sodium chloride and 7.2 mg of citrate
ions. The pH of the solution is between 5.0 to 7.5. The solution is packaged
in a multiple-dose glass vial and does not contain any preservative.
Physical Characteristics
Fluorine F 18 decays by positron (β+) emission and has a half-life
of 109.7 minutes. The principal photons useful for diagnostic imaging are the
511 keV gamma photons, resulting from the interaction of the emitted positron
with an electron (Table 1).
Table 1. Principal Emission Data for Fluorine F 18



Radiation/Emission
% per Disintegration
Mean Energy


Positron (β+)
96.73
249.8 keV


Gamma (±)*
193.46
511.0 keV


*Produced by positron annihilation
From: Kocher, D.C. "Radioactive Decay Tables" DOE/TIC-11026, 89 (1981).



External Radiation
The specific gamma ray constant for fluorine F 18 is 6.0 R/hr/mCi (0.3 Gy/hr/kB) at 1cm. The half-value layer (HVL) for the 511 keV photons is 4.1 mm lead (Pb). A range of values for the attenuation of radiation results from the interposition of various thickness of Pb. The range of attenuation coefficients for this radionuclide is shown in Table 2. For example, the interposition of an 8.3 mm thickness of Pb, with a coefficient of attenuation of 0.25, will decrease the external radiation by 75%.
Table 2. Radiation Attenuation of 511 keV Photons by Lead
(Pb) Shielding



Shield Thickness (Pb) mm
Coefficient of Attenuation


0
0.00


4.1
0.50


8.3
0.25


13.2
0.10


26.4
0.01


52.8
0.001



For use in correcting for physical decay of this radionuclide, the fractions remaining at selected intervals after calibration are shown in Table 3.
Table 3. Physical Decay Chart for Fluorine F 18



Minutes
Fraction Remaining


0*
1.00


15
0.909


30
0.826


60
0.683


110
0.500


220
0.250


440
0.060


* Calibration time


Last reviewed on RxList: 9/15/2008




Fludeoxyglucose F 18 Injection Drug Description
Fludeoxyglucose F 18 Injection
(FDG)
Diagnostic - For Intravenous Use Only
DRUG DESCRIPTION
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing
no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which
is used for diagnostic purposes in conjunction with Positron Emission Tomography
(PET). It is administered by intravenous injection.
The active ingredient 2-deoxy-2-[18F]fluoro-D-g1ucose (Fludeoxyglucose
F 18), abbreviated [18F] FDG, has a molecular formula of C6H1118FO5
with a molecular weight of 181.26 daltons, and has the following chemical structure:








Fludeoxyglucose F 18 Injection is provided as a ready to use isotonic, sterile,
pyrogen free, clear, colorless citrate buffered solution. Each mL contains between
0.37 to 3.7 GBq (10.0 - 100 mCi) of 2-deoxy-2-[18F]fluoro-D glucose
at the end of synthesis (EOS), 4.5 mg of sodium chloride and 7.2 mg of citrate
ions. The pH of the solution is between 5.0 to 7.5. The solution is packaged
in a multiple-dose glass vial and does not contain any preservative.
Physical Characteristics
Fluorine F 18 decays by positron (β+) emission and has a half-life
of 109.7 minutes. The principal photons useful for diagnostic imaging are the
511 keV gamma photons, resulting from the interaction of the emitted positron
with an electron (Table 1).
Table 1. Principal Emission Data for Fluorine F 18



Radiation/Emission
% per Disintegration
Mean Energy


Positron (β+)
96.73
249.8 keV


Gamma (±)*
193.46
511.0 keV


*Produced by positron annihilation
From: Kocher, D.C. "Radioactive Decay Tables" DOE/TIC-11026, 89 (1981).



External Radiation
The specific gamma ray constant for fluorine F 18 is 6.0 R/hr/mCi (0.3 Gy/hr/kB) at 1cm. The half-value layer (HVL) for the 511 keV photons is 4.1 mm lead (Pb). A range of values for the attenuation of radiation results from the interposition of various thickness of Pb. The range of attenuation coefficients for this radionuclide is shown in Table 2. For example, the interposition of an 8.3 mm thickness of Pb, with a coefficient of attenuation of 0.25, will decrease the external radiation by 75%.
Table 2. Radiation Attenuation of 511 keV Photons by Lead
(Pb) Shielding



Shield Thickness (Pb) mm
Coefficient of Attenuation


0
0.00


4.1
0.50


8.3
0.25


13.2
0.10


26.4
0.01


52.8
0.001



For use in correcting for physical decay of this radionuclide, the fractions remaining at selected intervals after calibration are shown in Table 3.
Table 3. Physical Decay Chart for Fluorine F 18



Minutes
Fraction Remaining


0*
1.00


15
0.909


30
0.826


60
0.683


110
0.500


220
0.250


440
0.060


* Calibration time


Last reviewed on RxList: 9/15/2008





Other reviews about FDG on wordpress

(FDG) FORDING CDN COAL has great dividend yield, cheap P/E and amazing growt rates.
  by deminvest
Frank Galotti's comment on the (PVR) Penn Virginia Resource article pointed out what a bargain is FDG. I checked and found that PVR has: P/E = 5.25 Dividend Yield = 11.60% Qtrly […]


FDG Training
  by ffanna
And I found out Adam was a nice guy after all. (Still don't know his last name whether it's Fate or Faith though.) He's been with HSBC for 14 […]


FGD Training
  by ffanna
I've been busy on other things it took me a while before I had this posted. It's been really smooth sailing at work, although now and then I have […]


Fording Canadian Coal (FDG) hit my 40% up target in such hard times!
  by deminvest
on July 13, 2006 I bought 50 FDG at USD 30.2 each spending a total amount of $1510. I wrote why I chose Fording […]


TOP PRE-MARKET ANALYST DOWNGRADES (ALU, EMN, FDG, GET, TAP, SEPR, SNE, WYE)
  by 247wallst
These are not all of the analyst downgrades and negative calls we are seeing this morning, but these are some of the stand out calls this Wednesday morning:Alcatel-Lucent […]


Teck Cominco to Get New Name, New Business Units (TCK, FDG, BHP, BTU)
  by 247wallst
Canadian miner Teck Cominco (NYSE:TCK) is changing its name to Teck Resources, and the company intends to build its brand just on the name Teck. The new […]


FDG upcoming game - Parachute Panic
  by iphonetech78
I received a demo video of Parachute Panic from FDG Entertainment - the guys who created Bobby Carrot Series of Games. Please note: Some sound effects and visuals are […]


FDG Entertainment launches unique casual game “Parachute Panic”.
  by iphonetech78
FDG Entertainment announces the launch of their new casual game, called “Parachute Panic” for the iPhone and iPod touch! It is available on the iTunes AppStore since today, May […]


Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
  by caduanselmi
Ann Nucl Med. 2009 Oct 16; Authors: Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A OBJECTIVE: Fluorodeoxyglucose (FDG) uptake in joint […]


PET-CT Beyond FDG: A Quick Guide to Image Interpretation
  by SinlorD
PET-CT Beyond FDG: A Quick Guide to Image Interpretation By Stefano Fanti, Mohsen Farsad, Luigi Mansi Publisher: Springer […]



Other reviews about FDG on web:

Fludeoxyglucose (18 F) or fluorodeoxyglucose (18 F), commonly abbreviated 18 F-FDG or FDG, is a radiopharmaceutical used in the medical imaging modality positron emission tomography (PET Fludeoxyglucose (18F) - Wikipedia, the free encyclopedia


FDG may refer to: Fludeoxyglucose (18F), used in medical imaging; Functional Discourse Grammar, grammar models and theories for natural languages FDG - Wikipedia, the free encyclopedia


Designed by Susan Loren Associates : www.fdgassociates.com © FdG Associates LLC 2004 FdG Associates :: Welcome


boi cap fdg vrn: 41.15: etf: ams: 2078743.nx: boi cap fdg vrn: 41.15: etf: enx: cnde.pk: citi fdg cntry sel: 6.20: stock: pnk: cifd.pk: citigrou fdg: 10.40: stock: pnk: ptsaj.pk: citigroup fdg Symbol Lookup from Yahoo! Finance


Learn about the prescription medication Fludeoxyglucose F 18 Injection (FDG), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Fludeoxyglucose F 18 Injection (FDG) Drug Information: Uses, Side ...


Welcome to the Website of Financial Decisions Group: Due to various state regulations and registration requirements concerning the dissemination of information regarding investment ... Welcome to the Website of Financial Decisions Group


Is PET Safe? What is a radiopharmaceutical? What is FDG? What happens after my scan? Are there potential side effects to a PET scan? When will I get my results? PET Scan: Frequently Asked Questions


Acronym Definition; FDG: Fluorodeoxyglucose: FDG: Foundations of Digital Games: FDG: Fundação de Desenvolvimento Gerencial: FDG: Function Dependence Graph: FDG FDG - What does FDG stand for? Acronyms and abbreviations by the ...


Embark on an epic adventure that will take you beyond anything you have ever experienced before! 1 year in the making! Tons of original ideas! FDG Entertainment - FDG Entertainment Website


FDG, Inc. is a specialty engineering firm servicing the precast/prestressed industry since 1991. We strive for excellence and superior custom customer satisfaction through ... FDG, Inc. : Precast/prestressed concrete consulting engineers





Featured Reviews

Reviews Celestone Syrup

Celestone Syrup Drug Description Celestone® (betamethasone) Syrup, USP DRUG DESCRIPTION What are the possible side effects of betamethasone (Celestone)? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Reviews Aminosyn RF 5.2% Sulfite Free

Aminosyn RF 5.2% Sulfite Free Drug Description Aminosyn®-RF 5.2% Sulfite-Free AN AMINO ACID INJECTION RENAL FORMULA Flexible Plastic Container DRUG DESCRIPTION Aminosyn®-RF 5.2%, Sulfite-Free, (an amino acid injection renal...
Read More  |  Review This
Reviews Cromolyn Sodium Inhalation Solution

Intal Nebulizer Solution Drug Description Intal® Nebulizer Solution (cromolyn sodium) Inhalation Solution, USP For Inhalation Use Only-Not for Injection DRUG DESCRIPTION What are the possible side effects of cromolyn sodium...
Read More  |  Review This
Reviews Saphris

Saphris Drug Description SAPHRIS® (asenapine) Sublingual Tablets WARNING INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs...
Read More  |  Review This
Reviews Iplex

Iplex Drug Description IPLEX™ (mecasermin rinfabate [rDNA origin]) Injection DRUG DESCRIPTION What are the possible side effects of mecasermin rinfabate (iPlex)? Stop using mecasermin rinfabate and get emergency medical help...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....